source
- Vivodyne’s Human Tissue Factory Wins Endpoints 11 2026, Promising Faster Drug TestingVivodyne was announced as the winner of the Endpoints 11 2026 competition for its human tissue factory technology. The platform creates human tissue constructs that can be used in preclinical drug…
- Jury awards Nektar $90 million in lawsuit against Eli Lilly over licensing disputeA federal jury in a US District Court awarded Nektar Therapeutics $90 million after finding Eli Lilly breached a licensing agreement. The verdict ends a dispute that began when the parties' licens…